Indivior PLC
Indivior PLC INDV.L Peers
See (INDV.L) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
---|---|---|---|---|---|---|
INDV.L | $844.50 | +2.30% | 1.05B | -211.12 | -$0.04 | N/A |
HLN.L | $404.00 | +0.60% | 36.44B | 25.25 | $0.16 | +0.02% |
HIK.L | $2,070.00 | -0.67% | 4.56B | 17.11 | $1.21 | +2.55% |
HCM.L | $205.00 | +1.11% | 1.79B | 68.33 | $0.03 | N/A |
0IRF.IL | $7.22 | +2.98% | 1.28B | -12.44 | -$0.58 | N/A |
APH.L | $64.70 | +0.02% | 349.75M | -32.35 | -$0.02 | N/A |
AGY.L | $7.25 | -0.41% | 345.57M | -7.25 | -$0.01 | N/A |
ANCR.L | $245.00 | -0.41% | 169.01M | 30.63 | $0.08 | +2.04% |
BMK.L | $22.60 | N/A | 167.58M | -3.77 | -$0.06 | N/A |
BXP.L | $36.00 | +2.64% | 160.60M | 4.00 | $0.09 | +9.30% |
Stock Comparison
INDV.L vs HLN.L Comparison
INDV.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV.L stands at 1.05B. In comparison, HLN.L has a market cap of 36.44B. Regarding current trading prices, INDV.L is priced at $844.50, while HLN.L trades at $404.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV.L currently has a P/E ratio of -211.12, whereas HLN.L's P/E ratio is 25.25. In terms of profitability, INDV.L's ROE is -0.01%, compared to HLN.L's ROE of +0.09%. Regarding short-term risk, INDV.L is more volatile compared to HLN.L. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.L.
INDV.L vs HIK.L Comparison
INDV.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV.L stands at 1.05B. In comparison, HIK.L has a market cap of 4.56B. Regarding current trading prices, INDV.L is priced at $844.50, while HIK.L trades at $2,070.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV.L currently has a P/E ratio of -211.12, whereas HIK.L's P/E ratio is 17.11. In terms of profitability, INDV.L's ROE is -0.01%, compared to HIK.L's ROE of +0.16%. Regarding short-term risk, INDV.L is more volatile compared to HIK.L. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.L.
INDV.L vs HCM.L Comparison
INDV.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV.L stands at 1.05B. In comparison, HCM.L has a market cap of 1.79B. Regarding current trading prices, INDV.L is priced at $844.50, while HCM.L trades at $205.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV.L currently has a P/E ratio of -211.12, whereas HCM.L's P/E ratio is 68.33. In terms of profitability, INDV.L's ROE is -0.01%, compared to HCM.L's ROE of -0.01%. Regarding short-term risk, INDV.L is less volatile compared to HCM.L. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.L.
INDV.L vs 0IRF.IL Comparison
INDV.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV.L stands at 1.05B. In comparison, 0IRF.IL has a market cap of 1.28B. Regarding current trading prices, INDV.L is priced at $844.50, while 0IRF.IL trades at $7.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV.L currently has a P/E ratio of -211.12, whereas 0IRF.IL's P/E ratio is -12.44. In terms of profitability, INDV.L's ROE is -0.01%, compared to 0IRF.IL's ROE of -0.22%. Regarding short-term risk, INDV.L is more volatile compared to 0IRF.IL. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.L.
INDV.L vs APH.L Comparison
INDV.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV.L stands at 1.05B. In comparison, APH.L has a market cap of 349.75M. Regarding current trading prices, INDV.L is priced at $844.50, while APH.L trades at $64.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV.L currently has a P/E ratio of -211.12, whereas APH.L's P/E ratio is -32.35. In terms of profitability, INDV.L's ROE is -0.01%, compared to APH.L's ROE of -0.05%. Regarding short-term risk, INDV.L is more volatile compared to APH.L. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.L.
INDV.L vs AGY.L Comparison
INDV.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV.L stands at 1.05B. In comparison, AGY.L has a market cap of 345.57M. Regarding current trading prices, INDV.L is priced at $844.50, while AGY.L trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV.L currently has a P/E ratio of -211.12, whereas AGY.L's P/E ratio is -7.25. In terms of profitability, INDV.L's ROE is -0.01%, compared to AGY.L's ROE of +20.72%. Regarding short-term risk, INDV.L is less volatile compared to AGY.L. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.L.
INDV.L vs ANCR.L Comparison
INDV.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV.L stands at 1.05B. In comparison, ANCR.L has a market cap of 169.01M. Regarding current trading prices, INDV.L is priced at $844.50, while ANCR.L trades at $245.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV.L currently has a P/E ratio of -211.12, whereas ANCR.L's P/E ratio is 30.63. In terms of profitability, INDV.L's ROE is -0.01%, compared to ANCR.L's ROE of +0.31%. Regarding short-term risk, INDV.L is more volatile compared to ANCR.L. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.L.
INDV.L vs BMK.L Comparison
INDV.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV.L stands at 1.05B. In comparison, BMK.L has a market cap of 167.58M. Regarding current trading prices, INDV.L is priced at $844.50, while BMK.L trades at $22.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV.L currently has a P/E ratio of -211.12, whereas BMK.L's P/E ratio is -3.77. In terms of profitability, INDV.L's ROE is -0.01%, compared to BMK.L's ROE of -0.18%. Regarding short-term risk, INDV.L is more volatile compared to BMK.L. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.L.
INDV.L vs BXP.L Comparison
INDV.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV.L stands at 1.05B. In comparison, BXP.L has a market cap of 160.60M. Regarding current trading prices, INDV.L is priced at $844.50, while BXP.L trades at $36.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV.L currently has a P/E ratio of -211.12, whereas BXP.L's P/E ratio is 4.00. In terms of profitability, INDV.L's ROE is -0.01%, compared to BXP.L's ROE of +0.13%. Regarding short-term risk, INDV.L is less volatile compared to BXP.L. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.L.
INDV.L vs 0W1Q.L Comparison
INDV.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV.L stands at 1.05B. In comparison, 0W1Q.L has a market cap of 114.31M. Regarding current trading prices, INDV.L is priced at $844.50, while 0W1Q.L trades at $26.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV.L currently has a P/E ratio of -211.12, whereas 0W1Q.L's P/E ratio is -12.76. In terms of profitability, INDV.L's ROE is -0.01%, compared to 0W1Q.L's ROE of +0.41%. Regarding short-term risk, INDV.L is more volatile compared to 0W1Q.L. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.L.
INDV.L vs VLG.L Comparison
INDV.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV.L stands at 1.05B. In comparison, VLG.L has a market cap of 67.87M. Regarding current trading prices, INDV.L is priced at $844.50, while VLG.L trades at $53.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV.L currently has a P/E ratio of -211.12, whereas VLG.L's P/E ratio is 53.00. In terms of profitability, INDV.L's ROE is -0.01%, compared to VLG.L's ROE of +0.01%. Regarding short-term risk, INDV.L is less volatile compared to VLG.L. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.L.
INDV.L vs EAH.L Comparison
INDV.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV.L stands at 1.05B. In comparison, EAH.L has a market cap of 42.35M. Regarding current trading prices, INDV.L is priced at $844.50, while EAH.L trades at $62.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV.L currently has a P/E ratio of -211.12, whereas EAH.L's P/E ratio is 62.50. In terms of profitability, INDV.L's ROE is -0.01%, compared to EAH.L's ROE of +0.01%. Regarding short-term risk, INDV.L is less volatile compared to EAH.L. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.L.
INDV.L vs STX.L Comparison
INDV.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV.L stands at 1.05B. In comparison, STX.L has a market cap of 24.48M. Regarding current trading prices, INDV.L is priced at $844.50, while STX.L trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV.L currently has a P/E ratio of -211.12, whereas STX.L's P/E ratio is -1.17. In terms of profitability, INDV.L's ROE is -0.01%, compared to STX.L's ROE of +68.33%. Regarding short-term risk, INDV.L is less volatile compared to STX.L. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.L.
INDV.L vs PXS.L Comparison
INDV.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV.L stands at 1.05B. In comparison, PXS.L has a market cap of 12.90M. Regarding current trading prices, INDV.L is priced at $844.50, while PXS.L trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV.L currently has a P/E ratio of -211.12, whereas PXS.L's P/E ratio is N/A. In terms of profitability, INDV.L's ROE is -0.01%, compared to PXS.L's ROE of -0.59%. Regarding short-term risk, INDV.L is less volatile compared to PXS.L. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.L.
INDV.L vs CHLL.L Comparison
INDV.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV.L stands at 1.05B. In comparison, CHLL.L has a market cap of 10.89M. Regarding current trading prices, INDV.L is priced at $844.50, while CHLL.L trades at $2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV.L currently has a P/E ratio of -211.12, whereas CHLL.L's P/E ratio is -2.15. In terms of profitability, INDV.L's ROE is -0.01%, compared to CHLL.L's ROE of -3.55%. Regarding short-term risk, INDV.L is more volatile compared to CHLL.L. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.L.
INDV.L vs MXC.L Comparison
INDV.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV.L stands at 1.05B. In comparison, MXC.L has a market cap of 9.30M. Regarding current trading prices, INDV.L is priced at $844.50, while MXC.L trades at $21.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV.L currently has a P/E ratio of -211.12, whereas MXC.L's P/E ratio is -0.13. In terms of profitability, INDV.L's ROE is -0.01%, compared to MXC.L's ROE of +26.60%. Regarding short-term risk, INDV.L is less volatile compared to MXC.L. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.L.
INDV.L vs RGT.L Comparison
INDV.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV.L stands at 1.05B. In comparison, RGT.L has a market cap of 4.18M. Regarding current trading prices, INDV.L is priced at $844.50, while RGT.L trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV.L currently has a P/E ratio of -211.12, whereas RGT.L's P/E ratio is -0.26. In terms of profitability, INDV.L's ROE is -0.01%, compared to RGT.L's ROE of +4.20%. Regarding short-term risk, INDV.L is less volatile compared to RGT.L. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.L.
INDV.L vs N4P.L Comparison
INDV.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV.L stands at 1.05B. In comparison, N4P.L has a market cap of 3.76M. Regarding current trading prices, INDV.L is priced at $844.50, while N4P.L trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV.L currently has a P/E ratio of -211.12, whereas N4P.L's P/E ratio is -0.47. In terms of profitability, INDV.L's ROE is -0.01%, compared to N4P.L's ROE of -0.91%. Regarding short-term risk, INDV.L is less volatile compared to N4P.L. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.L.
INDV.L vs CEL.L Comparison
INDV.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV.L stands at 1.05B. In comparison, CEL.L has a market cap of 3.44M. Regarding current trading prices, INDV.L is priced at $844.50, while CEL.L trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV.L currently has a P/E ratio of -211.12, whereas CEL.L's P/E ratio is -0.62. In terms of profitability, INDV.L's ROE is -0.01%, compared to CEL.L's ROE of -1.43%. Regarding short-term risk, INDV.L is less volatile compared to CEL.L. This indicates potentially lower risk in terms of short-term price fluctuations for INDV.L.
INDV.L vs HELD.L Comparison
INDV.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV.L stands at 1.05B. In comparison, HELD.L has a market cap of 1.40M. Regarding current trading prices, INDV.L is priced at $844.50, while HELD.L trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV.L currently has a P/E ratio of -211.12, whereas HELD.L's P/E ratio is N/A. In terms of profitability, INDV.L's ROE is -0.01%, compared to HELD.L's ROE of -3.64%. Regarding short-term risk, INDV.L is more volatile compared to HELD.L. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.L.
INDV.L vs 0A4X.L Comparison
INDV.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDV.L stands at 1.05B. In comparison, 0A4X.L has a market cap of 10.00. Regarding current trading prices, INDV.L is priced at $844.50, while 0A4X.L trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDV.L currently has a P/E ratio of -211.12, whereas 0A4X.L's P/E ratio is -0.00. In terms of profitability, INDV.L's ROE is -0.01%, compared to 0A4X.L's ROE of N/A. Regarding short-term risk, INDV.L is more volatile compared to 0A4X.L. This indicates potentially higher risk in terms of short-term price fluctuations for INDV.L.